Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7129075 Isolated CEL II endonuclease

Patent 7129075 was granted and assigned to TRANSGENOMIC, INC. on October, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

TRANSGENOMIC, INC.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Gary F. Gerard0

Harini Shandilya0

James M. D'Alessio0

Peter Qiu0

Date of Patent

October 31, 2006

Patent Application Number

10688665

Date Filed

October 17, 2003

Patent Citations Received

US Patent 11884916 Materials and methods for the synthesis of error-minimized nucleic acid molecules

0

US Patent 12086722 DNA-based digital information storage with sidewall electrodes

0

0

US Patent 12091777 Variant nucleic acid libraries for CRTH2

0

US Patent 11745159 Heated nanowells for polynucleotide synthesis

Patent Primary Examiner

Charles L. Patterson, Jr.

Patent abstract

The present invention relates to the isolation and characterization of CEL I and CEL II endonuclease proteins. Methods and kits for identifying mismatches in double-stranded DNA are also provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7129075 Isolated CEL II endonuclease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool